Cargando…

Glycosylation-independent Lysosomal Targeting of Acid α-Glucosidase Enhances Muscle Glycogen Clearance in Pompe Mice

We have used a peptide-based targeting system to improve lysosomal delivery of acid α-glucosidase (GAA), the enzyme deficient in patients with Pompe disease. Human GAA was fused to the glycosylation-independent lysosomal targeting (GILT) tag, which contains a portion of insulin-like growth factor II...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maga, John A., Zhou, Jianghong, Kambampati, Ravi, Peng, Susan, Wang, Xu, Bohnsack, Richard N., Thomm, Angela, Golata, Sarah, Tom, Peggy, Dahms, Nancy M., Byrne, Barry J., LeBowitz, Jonathan H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2013
Materias:	Molecular Bases of Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548456/ https://www.ncbi.nlm.nih.gov/pubmed/23188827 http://dx.doi.org/10.1074/jbc.M112.438663

Ejemplares similares

Lysosomal glycogen accumulation in Pompe disease results in disturbed cytoplasmic glycogen metabolism
por: Canibano‐Fraile, Rodrigo, et al.
Publicado: (2022)

Structure of human lysosomal acid α-glucosidase–a guide for the treatment of Pompe disease
por: Roig-Zamboni, Véronique, et al.
Publicado: (2017)

The Pharmacological Chaperone AT2220 Increases the Specific Activity and Lysosomal Delivery of Mutant Acid Alpha-Glucosidase, and Promotes Glycogen Reduction in a Transgenic Mouse Model of Pompe Disease
por: Khanna, Richie, et al.
Publicado: (2014)

The Release of a Soluble Glycosylated Protein from Glycogen by Recombinant Lysosomal α-Glucosidase (rhGAA) In Vitro and Its Presence in Serum In Vivo
por: Murray, Allen K.
Publicado: (2020)

TFEB overexpression promotes glycogen clearance of Pompe disease iPSC-derived skeletal muscle
por: Sato, Yohei, et al.
Publicado: (2016)

AAV Gene Therapy Utilizing Glycosylation-Independent Lysosomal Targeting Tagged GAA in the Hypoglossal Motor System of Pompe Mice
por: Doyle, Brendan M., et al.
Publicado: (2019)

1,6-epi-Cyclophellitol Cyclosulfamidate Is a Bona Fide Lysosomal α-Glucosidase Stabilizer for the Treatment of Pompe Disease
por: Kok, Ken, et al.
Publicado: (2022)

The Pharmacological Chaperone AT2220 Increases Recombinant Human Acid α-Glucosidase Uptake and Glycogen Reduction in a Mouse Model of Pompe Disease
por: Khanna, Richie, et al.
Publicado: (2012)

Glycogen accumulation in smooth muscle of a Pompe disease mouse model
por: McCall, Angela L., et al.
Publicado: (2021)

From Acid Alpha-Glucosidase Deficiency to Autophagy: Understanding the Bases of POMPE Disease
por: Sánchez-Porras, Valentina, et al.
Publicado: (2023)

Dysregulation of Multiple Facets of Glycogen Metabolism in a Murine Model of Pompe Disease
por: Taylor, Kristin M., et al.
Publicado: (2013)

Pompe disease: Shared and unshared features of lysosomal storage disorders
por: Lim, Jeong-A, et al.
Publicado: (2015)

Pompe Disease: New Developments in an Old Lysosomal Storage Disorder
por: Meena, Naresh K., et al.
Publicado: (2020)

Rescue of Advanced Pompe Disease in Mice with Hepatic Expression of Secretable Acid α-Glucosidase
por: Cagin, Umut, et al.
Publicado: (2020)

β(2)-Microglobulin Amyloid Fibrils Are Nanoparticles That Disrupt Lysosomal Membrane Protein Trafficking and Inhibit Protein Degradation by Lysosomes
por: Jakhria, Toral, et al.
Publicado: (2014)

Glycogen Reduction in Myotubes of Late-Onset Pompe Disease Patients Using Antisense Technology
por: Goina, Elisa, et al.
Publicado: (2017)

Correlation of GAA Genotype and Acid-α-Glucosidase Enzyme Activity in Hungarian Patients with Pompe Disease
por: Gal, Aniko, et al.
Publicado: (2021)

Distribution of Exonic Variants in Glycogen Synthesis and Catabolism Genes in Late Onset Pompe Disease (LOPD)
por: De Filippi, Paola, et al.
Publicado: (2023)

Aortopathies in mouse models of Pompe, Fabry and Mucopolysaccharidosis IIIB lysosomal storage diseases
por: Belfiore, Maria Paola, et al.
Publicado: (2020)

A Nonsense Mutation in the Acid α-Glucosidase Gene Causes Pompe Disease in Finnish and Swedish Lapphunds
por: Seppälä, Eija H., et al.
Publicado: (2013)

Duvoglustat HCl Increases Systemic and Tissue Exposure of Active Acid α-Glucosidase in Pompe Patients Co-administered with Alglucosidase α
por: Kishnani, Priya, et al.
Publicado: (2017)

The Pompe Registry: tracking Pompe disease symptoms in a broad patient population
por: Byrne, B, et al.
Publicado: (2008)

Abnormal mannose-6-phosphate receptor trafficking impairs recombinant alpha-glucosidase uptake in Pompe disease fibroblasts
por: Cardone, Monica, et al.
Publicado: (2008)

Three years experience with dried blood spot α-glucosidase screening for Pompe disease in British Columbia, Canada
por: Horvath, Gabriella, et al.
Publicado: (2013)

Molecular Diagnosis of Pompe Disease in the Genomic Era: Correlation with Acid Alpha-Glucosidase Activity in Dried Blood Spots
por: Thuriot, Fanny, et al.
Publicado: (2021)

Lentiviral gene therapy prevents anti-human acid α-glucosidase antibody formation in murine Pompe disease
por: Liang, Qiushi, et al.
Publicado: (2022)

AAV-mediated delivery of secreted acid α-glucosidase with enhanced uptake corrects neuromuscular pathology in Pompe mice
por: Meena, Naresh K., et al.
Publicado: (2023)

Effects of intrapulmonary percussive ventilation on airway mucus clearance: A bench model
por: Fernandez-Restrepo, Lorena, et al.
Publicado: (2017)

Novel Mutation in the Feline GAA Gene in a Cat with Glycogen Storage Disease Type II (Pompe Disease)
por: Rakib, Tofazzal Md, et al.
Publicado: (2023)

Carnitine is a pharmacological allosteric chaperone of the human lysosomal α-glucosidase
por: Iacono, Roberta, et al.
Publicado: (2021)

Tophaceous gout in a female premenopausal patient with an unexpected diagnosis of glycogen storage disease type Ia: a case report and literature review
por: Zhang, Bingqing, et al.
Publicado: (2016)

Identification of Seven Novel Mutations in the Acid Alpha-glucosidase Gene in Five Chinese Patients with Late-onset Pompe Disease
por: Liu, Hua-Xu, et al.
Publicado: (2018)

Antibodies against recombinant human alpha-glucosidase do not seem to affect clinical outcome in childhood onset Pompe disease
por: van Kooten, Harmke A., et al.
Publicado: (2022)

Hallmarks of glycogene expression and glycosylation pathways in squamous and adenocarcinoma cervical cancer
por: Martinez-Morales, Patricia, et al.
Publicado: (2021)

Late-Onset Glycogen Storage Disease Type II (Pompe's Disease) with a Novel Mutation: A Malaysian Experience
por: Fu Liong, Hiew, et al.
Publicado: (2014)

Antisense Oligonucleotide-mediated Suppression of Muscle Glycogen Synthase 1 Synthesis as an Approach for Substrate Reduction Therapy of Pompe Disease
por: Clayton, Nicholas P, et al.
Publicado: (2014)

Clinical manifestations and acid alpha-glucosidase mutation characterisation of a cohort of patients with late-onset Pompe disease in eastern China
por: Zhao, Hui-Hui, et al.
Publicado: (2021)

The Novel PMCA2 Pump Mutation Tommy Impairs Cytosolic Calcium Clearance in Hair Cells and Links to Deafness in Mice
por: Bortolozzi, Mario, et al.
Publicado: (2010)

Transcriptional Activation of Lysosomal Exocytosis Promotes Cellular Clearance
por: Medina, Diego L., et al.
Publicado: (2011)

Abnormal expression of lysosomal glycoproteins in patients with congenital disorders of glycosylation
por: Sabry, Sahar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8rj9iu9he1dkbjmc5pb814h54a